Colgate-Palmolive
Colgate-Palmolive (CL) is a global consumer products company that sells oral care, personal care, home cleaning products and pet nutrition. Its Oral Care business, led by Colgate toothpaste and toothbrushes, is a major focus for analysts, alongside its Hill’s Pet Nutrition business, which sells specialized food for dogs and cats.
高露洁棕榄(Colgate-Palmolive,股票代码:CL)是一家全球消费品公司,主要销售口腔护理、个人护理、家居清洁产品及宠物营养产品。其以高露洁牙膏和牙刷为核心的口腔护理业务,以及为猫狗提供专业营养食品的 Hill’s 宠物营养业务,都是分析师重点关注的领域。
Every figure on this page is tipranks’s, read on 2026-10-27 and linked below.
SmartChecker Colgate-Palmolive Forecast
The forecast in short
tipranks records 12 analyst ratings on Colgate-Palmolive and summarises them as “Moderate Buy”. Their average 12-month price target is 98.33 (5.62% Upside). Its tipranks score is 7 out of 10 — Neutral. These are tipranks’s figures as SmartChecker read them on 2026-10-27, not SmartChecker’s own view, and nothing here is advice to buy or sell.
Market cap
USD 74.97 B
≈ Maybank x 2
Share price
USD 93.10
≈ RM 380.36
#333World ranking
tipranks score
Neutral
Analyst ratings
Moderate Buy
- Buy8 67%
- Hold4 33%
- Sell0 0%
tipranks’s own summary of the 12 ratings above.
12 months price forecast
98.33 5.62% Upside
As tipranks publishes it. SmartChecker has not recalculated any of it.
Analyst profiles. Who made each call, and when.
| Analyst | From | Position | Target price | Dated |
|---|---|---|---|---|
| Andrea Faria Teixeira | J.P. Morgan | Buy | USD 104 | 2026-10-19 |
| Lauren Lieberman | Barclays | Hold | USD 87 | 2026-10-16 |
| Peter Grom | UBS | Buy | USD 106 | 2026-10-15 |
| Peter Galbo | Bank of America Securities | Buy | USD 100 | 2026-10-09 |
| Nik Modi | RBC Capital | Buy | USD 104 | 2026-10-06 |
| Christopher Carey | Wells Fargo | Hold | USD 90 | 2026-10-05 |
| Bonnie Herzog | Goldman Sachs | Buy | USD 100 | 2026-10-05 |
| Michael Lavery | Piper Sandler | Buy | USD 95 | 2026-09-21 |
| Unknown Analyst | Bernstein | Hold | USD 99 | 2026-09-15 |
| Robert Moskow | TD Cowen | Hold | USD 90 | 2026-08-03 |
| Stephen Powers | Deutsche Bank | Buy | USD 101 | 2026-08-03 |
| Dara Mohsenian | Morgan Stanley | Buy | USD 104 | 2026-08-03 |
| Filippo Falorni | Citi | Buy | USD 110 | 2026-07-14 |
| Taylor Conrad | Argus Research | Hold | N/A | 2026-06-09 |
| Robert Ottenstein | Evercore ISI | Buy | USD 100 | 2026-06-08 |
| Andy Sim | DBS | Hold | USD 95 | 2026-05-03 |
| Kaumil Gajrawala | Jefferies | Hold | USD 88 | 2026-04-21 |
| Edward Lewis | Rothschild & Co Redburn | Buy | USD 100 | 2026-04-21 |
Show moreShow less
Investment Strengths
Free Cash Flow Generation
Consistent, large free cash flow (TTM ~$3.86B) funds dividends, buybacks and debt service, enabling durable capital allocation. Strong operating cash flow (~$4.46B) supports investment in brands, innovation and working capital, and provides a buffer through cycles.
Emerging Markets Revenue Strength
Broad-based organic growth led by emerging markets (mid-single digits) and standout country performance (India double-digits) diversifies revenue sources. Geographic breadth reduces dependence on any single economy and supports more stable long-term top-line growth.
Hill's Premium Pet Franchise
Hill's operates as a premium, higher-margin franchise with therapeutic and wet segments growing and e-commerce momentum. Its pricing power, clinical positioning and category mix offer durable structural tailwinds and a stable profit contributor over time.
People also ask
What is the 12-month price target for Colgate-Palmolive (CL)?
tipranks publishes an average 12-month price target of 98.33 (5.62% Upside), as SmartChecker read it on 2026-10-27. The highest target is USD 106 and the lowest is USD 87. A price target is an analyst’s estimate of where a share might trade, not a promise, and SmartChecker gives no investment advice.
See tipranks’s own page ↗How many analysts cover Colgate-Palmolive (CL)?
tipranks records 12 analyst ratings: 8 buy, 4 hold and 0 sell, which it summarises as “Moderate Buy”, as SmartChecker read it on 2026-10-27.
See tipranks’s own page ↗What is the tipranks score for Colgate-Palmolive (CL)?
tipranks scores it 7 out of 10 and calls that “Neutral”, as SmartChecker read it on 2026-10-27. The score is tipranks’s, not SmartChecker’s, and SmartChecker does not rate listed shares.
See tipranks’s own page ↗Is this SmartChecker’s own forecast for Colgate-Palmolive?
No. Every figure on this page is published by tipranks, copied on 2026-10-27 with a link to the original, and not recalculated. SmartChecker assesses financial companies in Malaysia against the public registers; it makes no forecast of its own and holds no licence to advise on securities.
See tipranks’s own page ↗Member reviews. Members’ own ratings and words, not SmartChecker’s rating.
These ratings and words are written by SmartChecker members and published immediately without administrator approval. SmartChecker does not rate listed companies: a rating here belongs to whoever wrote it, it counts towards no score of ours, and nothing in it is advice.
Disclaimer
SmartChecker provides informational and financial market news only and does not provide investment, financial or legal advice.
